Dry coating of solid dosage forms: an overview of processes and applications

References

• Porter SC. Coatings of pharmaceutical dosage forms. In: Felton LA, editor. Remington essentials of pharmaceutics. London (UK): Pharmaceutical Press; 2013. p. 611–622.
   Google Scholar
• Bose S, Bogner RH. Solventless pharmaceutical coating processes: a review. Pharm Dev Technol. 2007;12:115–131.
   PubMed Web of Science ®Google Scholar
• Luo YF, Zhu J, Ma YL, et al. Dry coating, a novel coating technology for solid pharmaceutical dosage forms. Int J Pharm. 2008;358:16–22.
   PubMed Web of Science ®Google Scholar
• Sauer D, Cerea M, DiNunzio J, et al. Dry powder coating of pharmaceuticals: a review. Int J Pharm. 2013;457:488–502.
   PubMed Web of Science ®Google Scholar
• Sangalli ME, Maroni A, Zema L, et al. ChronotopicTM technology. In: Youan BBC, editor. Chronopharmaceutics: science and technology for biological rhythm-guided therapy and prevention of diseases. Hoboken (NJ): John Wiley & Sons, Inc.; 2009. p. 145–163.
   Google Scholar
• Cerea M, Zema L, Palugan L, et al. Recent developments in dry coating. Pharm Technol Eur. 2008;20:40–44.
   Google Scholar
• Achanta AS, Adusumilli PS, James KW, et al. Development of hot melt coating methods. Drug Dev Ind Pharm. 1997;23:441–449.
   Web of Science ®Google Scholar
• Jozwiakowski MJ, Jones DM, Franz RM. Characterization of a hot-melt fluid bed coating process for fine granules. Pharm Res. 1990;7:1119–1126.
   PubMed Web of Science ®Google Scholar
• Jannin V, Cuppok Y. Hot-melt coating with lipid excipients. Int J Pharm. 2013;457:480–487.
   PubMed Web of Science ®Google Scholar
• Kennedy JP, Niebergall PJ. Development and optimization of a solid dispersion hot-melt fluid bed coating method. Pharm Dev Technol. 1996;1:51–62.
   PubMedGoogle Scholar
• Griffin EN, Niebergall PJ. Release kinetics of a controlled-release multiparticulate dosage form prepared using a hot-melt fluid bed coating method. Pharm Dev Technol. 1999;4:117–124.
   PubMed Web of Science ®Google Scholar
• Kennedy JP, Niebergall PJ. Evaluation of extended-release applications for solid dispersion hot-melt fluid bed coatings utilizing hydrophobic coating agents. Pharm Dev Technol. 1998;3:95–101.
   PubMedGoogle Scholar
• Chen H, Shi SA, Liu AN, et al. Combined application of extrusion-spheronization and hot-melt coating technologies for improving moisture-proofing of herbal extracts. J Pharm Sci. 2010;99:2444–2454.
   PubMed Web of Science ®Google Scholar
• Rodriguez L, Albertini B, Passerini N, et al. Hot air coating technique as a novel method to produce microparticles. Drug Dev Ind Pharm. 2004;30:913–923.
   PubMed Web of Science ®Google Scholar
• Giovannelli L, Bellomi S, Pattarino F, et al. Characterization of nifedipine microparticles prepared by hot air coating technique. Int J Pharm. 2005;293:225–234.
   PubMed Web of Science ®Google Scholar
• Pattarino F, Giovannelli L, Bellomi S. Effect of poloxamers on nifedipine microparticles prepared by hot air coating technique. Eur J Pharm Biopharm. 2007;65:198–203.
   PubMed Web of Science ®Google Scholar
• Becker K, Salar-Behzadi S, Zimmer A. Solvent-free melting techniques for the preparation of lipid-based solid oral formulations. Pharm Res. 2015;32:1519–1545.
   PubMed Web of Science ®Google Scholar
• Barthelemy P, Laforet JP, Farah N, et al. Compritol 888 ATO: an innovative hot-melt coating agent for prolonged-release drug formulations. Eur J Pharm Biopharm. 1999;47:87–90.
   PubMed Web of Science ®Google Scholar
• Knezevic Z, Gosak D, Hraste M, et al. Application of hot-melt coating process for designing a lipid based controlled release drug delivery system for highly aqueous soluble drugs. Chem Pharm Bull. 2009;57:464–471.
   PubMed Web of Science ®Google Scholar
• Sinchaipanid N, Junyaprasert V, Mitrevej A. Application of hot-melt coating for controlled release of propranolol hydrochloride pellets. Powder Technol. 2004;141:203–209.
   Web of Science ®Google Scholar
• Faham A, Prinderre P, Farah N, et al. Hot-melt coating technology. I. Influence of Compritol 888 ATO and granule size on theophylline release. Drug Dev Ind Pharm. 2000;26:167–176.
   PubMed Web of Science ®Google Scholar
• Chansanroj K, Betz G, Leuenberger H, et al. Development of a multi-unit floating drug delivery system by hot melt coating technique with drug-lipid dispersion. J Drug Deliv Sci Technol. 2007;17:333–338.
   Web of Science ®Google Scholar
• Patil A, Chafle S, Khobragade D, et al. Evaluation of hot melt coating as taste masking tool. Int Res J Pharm. 2011;2:169–172.
   Google Scholar
• Becker K, Saurugger E-M, Kienberger D, et al. Advanced stable lipid-based formulations for a patient-centric product design. Int J Pharm. 2016;497:136–149.
   PubMed Web of Science ®Google Scholar
• Wang JZY, Bogner RH. Solvent-free film coating using a novel photocurable polymer. Int J Pharm. 1995;119:81–89.
   Web of Science ®Google Scholar
• Bose S, Kelly B, Bogner RH. Design space for a solventless photocurable pharmaceutical coating. J Pharm Innov. 2006;1:44–53.
   Google Scholar
• Bose S, Bogner RH. Solventless photocurable film coating: evaluation of drug release, mechanical strength, and photostability. AAPS PharmSciTech. 2007;8:E42–E51.
   Web of Science ®Google Scholar
• Bose S, Bogner RH. Solventless visible light-curable coating: I. Critical formulation and processing parameters. Int J Pharm. 2010;393:32–40.
   PubMed Web of Science ®Google Scholar
• Bose S, Bogner RH. Solventless visible light-curable coating: II. Drug release, mechanical strength and photostability. Int J Pharm. 2010;393:41–47.
   PubMed Web of Science ®Google Scholar
• Coclite AM. Smart surfaces by initiated chemical vapor deposition. Surf Innov. 2013;1:6–14.
   Web of Science ®Google Scholar
• Lau KKS, Gleason KK. Initiated chemical vapor deposition (iCVD) of copolymer thin films. Thin Solid Films. 2008;516:678–680.
   Web of Science ®Google Scholar
• Lau KKS, Gleason KK. Particle functionalization and encapsulation by initiated chemical vapor deposition (iCVD). Surf Coat Technol. 2007;201:9189–9194.
   Web of Science ®Google Scholar
• McInnes SJP, Szili EJ, Al-Bataineh SA, et al. Fabrication and characterization of a porous silicon drug delivery system with an initiated chemical vapor deposition temperature-responsive coating. Langmuir. 2016;32:301–308.
   PubMed Web of Science ®Google Scholar
• McInnes SJP, Szili EJ, Al-Bataineh SA, et al. Combination of iCVD and porous silicon for the development of a controlled drug delivery system. ACS Appl Mater Interfaces. 2012;4:3566–3574.
   PubMed Web of Science ®Google Scholar
• Karimi M, Zangabad PS, Ghasemi A, et al. Temperature-responsive smart nanocarriers for delivery of therapeutic agents: applications and recent advances. ACS Appl Mater Interfaces. 2016;8:21107–21133.
   PubMed Web of Science ®Google Scholar
• Christian P, Ehmann HMA, Coclite AM, et al. Polymer encapsulation of an amorphous pharmaceutical by initiated chemical vapor deposition for enhanced stability. ACS Appl Mater Interfaces. 2016;8:21177–21184.
   PubMed Web of Science ®Google Scholar
• Blubaugh FC, Zapapas JR, Sparks MC. An enteric compression coating. I. In vitro studies. J Am Pharm Assoc. 1958;47:857–862.
   Google Scholar
• Ozeki Y, Ando M, Watanabe Y, et al. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets. J Control Release. 2004;95:51–60.
   PubMed Web of Science ®Google Scholar
• Maroni A, Zema L, Loreti G, et al. Film coatings for oral pulsatile release. Int J Pharm. 2013;457:362–371.
   PubMed Web of Science ®Google Scholar
• Maroni A, Del Curto MD, Zema L, et al. Film coatings for oral colon delivery. Int J Pharm. 2013;457:372–394.
   PubMed Web of Science ®Google Scholar
• Lin SY, Kawashima Y. Current status and approaches to developing press-coated chronodelivery drug systems. J Control Release. 2012;157:331–353.
   PubMed Web of Science ®Google Scholar
• Maroni A, Zema L, Cerea M, et al. Erodible drug delivery systems for time-controlled release into the gastrointestinal tract. J Drug Deliv Sci Technol. 2016;32:229–235.
   Web of Science ®Google Scholar
• Gazzaniga A, Sangalli ME, Giordano F. Oral chronotopic drug-delivery systems – achievement of time and or site-specificity. Eur J Pharm Biopharm. 1994;40:246–250.
   Web of Science ®Google Scholar
• Halsas M, Penttinen T, Veski P, et al. Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations. Pharmazie. 2001;56:718–723.
   PubMed Web of Science ®Google Scholar
• Ghimire M, McInnes FJ, Watson DG, et al. In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: a pharmacoscintigraphic study in the beagle dog. Eur J Pharm Biopharm. 2007;67:515–523.
   PubMed Web of Science ®Google Scholar
• Halsas M, Ervasti P, Veski P, et al. Biopharmaceutical evaluation of time-controlled press-coated tablets containing polymers to adjust drug release. Eur J Drug Metab Pharmacokinet. 1998;23:190–196.
   PubMed Web of Science ®Google Scholar
• Halsas M, Simelius R, Kiviniemi A, et al. Effect of different combinations of hydroxypropylmethyl cellulose on bioavailability of ibuprofen from press-coated time-controlled tablets. STP Pharma Sci. 1998;8:155–161.
   Google Scholar
• Karavas E, Georgarakis E, Bikiaris D. Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. Int J Pharm. 2006;313:189–197.
   PubMed Web of Science ®Google Scholar
• Li YH, Zhu JB. Modulation of combined-release behaviors from a novel “tablets-in-capsule system”. J Control Release. 2004;95:381–389.
   PubMed Web of Science ®Google Scholar
• Qureshi J, Ahuja A, Baboota S, et al. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis. Methods Find Exp Clin Pharmacol. 2009;31:15–23.
   PubMedGoogle Scholar
• Matsuo M, Arimori K, Nakamura C, et al. Delayed-release tablets using hydroxyethylcellulose as a gel-forming matrix. Int J Pharm. 1996;138:225–235.
   Web of Science ®Google Scholar
• Sawada T, Kondo H, Nakashima H, et al. Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy. Int J Pharm. 2004;280:103–111.
   PubMed Web of Science ®Google Scholar
• Efentakis M, Koligliati S, Vlachou M. Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release. Int J Pharm. 2006;311:147–156.
   PubMed Web of Science ®Google Scholar
• Songa AS, Meka VS, Nali SR, et al. An in vitro and in vivo investigation into the suitability of compression coated tablets of indomethacin for the treatment of rheumatoid arthritis which follow circadian rhythms. Drug Dev Ind Pharm. 2013;39:447–456.
   PubMed Web of Science ®Google Scholar
• Jain V, Jain D, Singh R. Factors effecting the morphology of eudragit S-100 based microsponges bearing dicyclomine for colonic delivery. J Pharm Sci. 2011;100:1545–1552.
   PubMed Web of Science ®Google Scholar
• Orlu M, Cevher E, Araman A. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm. 2006;318:103–117.
   PubMed Web of Science ®Google Scholar
• Ugurlu T, Turkoglu M, Gurer US, et al. Colonic delivery of compression coated nisin tablets using pectin/HPMC polymer mixture. Eur J Pharm Biopharm. 2007;67:202–210.
   PubMed Web of Science ®Google Scholar
• Krishnaiah YSR, Muzib YI, Bhaskar P, et al. Pharmacokinetic evaluation of guar gum-based colon-targeted drug delivery systems of tinidazole in healthy human volunteers. Drug Deliv. 2003;10:263–268.
   Google Scholar
• Sinha VR, Mittal BR, Kumria R. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery. Int J Pharm. 2005;289:79–85.
   PubMed Web of Science ®Google Scholar
• Raghavan CV, Muthulingam C, Jenita J, et al. An in vitro and in vivo investigation into the suitability of bacterially triggered delivery system for colon targeting. Chem Pharm Bull. 2002;50:892–895.
   PubMed Web of Science ®Google Scholar
• Staniforth JN, Baichwal AR. TIMERx: novel polysaccharide composites for controlled/programmed release of drugs in the gastrointestinal tract. Expert Opin Drug Deliv. 2005;2:587–595.
   PubMedGoogle Scholar
• Baichwall A, Sciascia T. From oral drug delivery technology to proprietary product development [Internet]. 2007 [cited 2017 Apr 28]. p. 7–10. Available from: http://www.ondrugdelivery.com/publications/Oral_Drug_Delivery_07.pdf
   Google Scholar
• Yehia SA, Elshafeey AH, Sayed I, et al. Optimization of budesonide compression-coated tablets for colonic delivery. AAPS PharmSciTech. 2009;10:147–157.
   PubMed Web of Science ®Google Scholar
• Rujivipat S, Bodmeier R. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends. Eur J Pharm Biopharm. 2010;76:486–492.
   PubMed Web of Science ®Google Scholar
• Fukui E, Miyamura N, Kobayashi M. An in vitro investigation of the suitability of press-coated tablets with hydroxypropylmethylcellulose acetate succinate (HPMCAS) and hydrophobic additives in the outer shell for colon targeting. J Control Release. 2001;70:97–107.
   PubMed Web of Science ®Google Scholar
• Jain D, Raturi R, Jain V, et al. Recent technologies in pulsatile drug delivery systems. Biomatter. 2011;1:57–65.
   PubMedGoogle Scholar
• Cerea M, Zheng WJ, Young CR, et al. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets. Int J Pharm. 2004;279:127–139.
   PubMed Web of Science ®Google Scholar
• Zheng W, Cerea M, Sauer D, et al. Properties of theophylline tablets powder-coated with methacrylate ester copolymers. J Drug Deliv Sci Technol. 2004;14:319–325.
   Web of Science ®Google Scholar
• Sauer D, Zheng W, Coots LB, et al. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit® L 100-55. Eur J Pharm Biopharm. 2007;67:464–475.
   PubMed Web of Science ®Google Scholar
• Sauer D, Watts AB, Coots LB, et al. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit® L 100-55. Int J Pharm. 2009;367:20–28.
   PubMed Web of Science ®Google Scholar
• Sauer D, McGinity J. Properties of theophylline tablets dry powder coated with Eudragit (R) E PO and Eudragit® L 100-55. Pharm Dev Technol. 2009;14:632–641.
   PubMed Web of Science ®Google Scholar
• Albertini B, Bertoni S, Melegari C, et al. A novel approach for dry powder coating of pellets with Ethylcellulose. Part I: evaluation of film formulation and process set up. Int J Pharm. 2017;516:380–391.
   PubMed Web of Science ®Google Scholar
• Obara S, Maruyama N, Nishiyama Y, et al. Dry coating: an innovative enteric coating method using a cellulose derivative. Eur J Pharm Biopharm. 1999;47:51–59.
   PubMed Web of Science ®Google Scholar
• Cerea M, Foppoli A, Maroni A, et al. Dry coating of soft gelatin capsules with HPMCAS. Drug Dev Ind Pharm. 2008;34:1196–1200.
   PubMed Web of Science ®Google Scholar
• Kablitz CD, Harder K, Urbanetz NA. Dry coating in a rotary fluid bed. Eur J Pharm Sci. 2006;27:212–219.
   PubMed Web of Science ®Google Scholar
• Kablitz CD, Kappl M, Urbanetz NA. Parameters influencing polymer particle layering of the dry coating process. Eur J Pharm Biopharm. 2008;69:760–768.
   PubMed Web of Science ®Google Scholar
• Kablitz CD, Urbanetz NA. Characterization of the film formation of the dry coating process. Eur J Pharm Biopharm. 2007;67:449–457.
   PubMed Web of Science ®Google Scholar
• Kablitz CD, Urbanetz NA. Stability of dry coated solid dosage forms. Pharm Dev Technol. 2009;14:613–622.
   PubMed Web of Science ®Google Scholar
• Kablitz CD, Urbanetz NA. Evaluating the process parameters of the dry coating process using a 2(5-1) factorial design. Pharm Dev Technol. 2013;18:39–45.
   PubMed Web of Science ®Google Scholar
• Klar F, Urbanetz NA. The role of capillary force promoters in dry coating procedures - Evaluation of acetylated monoglyceride, isopropyl myristate and palmitate. Eur J Pharm Biopharm. 2009;71:124–129.
   PubMed Web of Science ®Google Scholar
• Klar F, Urbanetz NA. Solubility parameters of hypromellose acetate succinate and plasticization in dry coating procedures. Drug Dev Ind Pharm. 2016;42:1621–1635.
   PubMed Web of Science ®Google Scholar
• Smikalla M, Mescher A, Walzel P, et al. Impact of excipients on coating efficiency in dry powder coating. Int J Pharm. 2011;405:122–131.
   PubMed Web of Science ®Google Scholar
• Park HJ, Lee GH, Jun JH, et al. Formulation and in vivo evaluation of probiotics-encapsulated pellets with hydroxypropyl methylcellulose acetate succinate (HPMCAS). Carbohydr Polym. 2016;136:692–699.
   PubMed Web of Science ®Google Scholar
• Pearnchob N, Bodmeier R. Dry powder coating of pellets with micronized Eudragit® RS for extended drug release. Pharm Res. 2003;20:1970–1976.
   PubMed Web of Science ®Google Scholar
• Pearnchob N, Bodmeier R. Dry polymer powder coating and comparison with conventional liquid-based coatings for Eudragit® RS, ethylcellulose and shellac. Eur J Pharm Biopharm. 2003;56:363–369.
   PubMed Web of Science ®Google Scholar
• Pearnchob N, Bodmeier R. Coating of pellets with micronized ethylcellulose particles by a dry powder coating technique. Int J Pharm. 2003;268:1–11.
   PubMed Web of Science ®Google Scholar
• Terebesi I, Bodmeier R. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets. Eur J Pharm Biopharm. 2010;75:63–70.
   PubMed Web of Science ®Google Scholar
• Prasad LK, McGinity JW, Williams RO. Electrostatic powder coating: principles and pharmaceutical applications. Int J Pharm. 2016;505:289–302.
   PubMed Web of Science ®Google Scholar
• Prasad LK, LaFountaine JS, Keen JM, et al. Influence of process parameters on the preparation of pharmaceutical films by electrostatic powder deposition. Int J Pharm. 2016;515:94–103.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Ghadiri M, Matsuyama T, et al. Triboelectrification of pharmaceutical powders by particle impact. Int J Pharm. 2007;334:149–155.
   PubMed Web of Science ®Google Scholar
• Pu Y, Mazumder M, Cooney C. Effects of electrostatic charging on pharmaceutical powder blending homogeneity. J Pharm Sci. 2009;98:2412–2421.
   PubMed Web of Science ®Google Scholar
• Hao T, Tukianen J, Nivorozhkin A, et al. Probing pharmaceutical powder blending uniformity with electrostatic charge measurements. Powder Technol. 2013;245:64–69.
   Web of Science ®Google Scholar
• Prasad LK, Keen JM, LaFountaine JS, et al. Electrostatic powder deposition to prepare films for drug delivery. J Drug Deliv Sci Technol. 2015;30:501–510.
   Web of Science ®Google Scholar
• Eilbeck J, Rowley G, Carter PA, et al. Effect of contamination of pharmaceutical equipment on powder triboelectrification. Int J Pharm. 2000;195:7–11.
   PubMed Web of Science ®Google Scholar
• Matsusaka S, Maruyama H, Matsuyama T, et al. Triboelectric charging of powders: a review. Chem Eng Sci. 2010;65:5781–5807.
   Web of Science ®Google Scholar
• Grosvenor MP, Staniforth JN. The influence of water on electrostatic charge retention and dissipation in pharmaceutical compacts for powder coating. Pharm Res. 1996;13:1725–1729.
   PubMed Web of Science ®Google Scholar
• Qiao MX, Zhang LQ, Ma YL, et al. A novel electrostatic dry powder coating process for pharmaceutical dosage forms: immediate release coatings for tablets. Eur J Pharm Biopharm. 2010;76:304–310.
   PubMed Web of Science ®Google Scholar
• Qiao MX, Luo YF, Zhang LQ, et al. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process. Int J Pharm. 2010;399:37–43.
   PubMed Web of Science ®Google Scholar
• Yang QL, Ma YL, Zhu J. Sustained drug release from electrostatic powder coated tablets with ultrafine ethylcellulose powders. Adv Powder Technol. 2016;27:2145–2152.
   Web of Science ®Google Scholar
• Qiao MX, Zhang LQ, Ma YL, et al. A novel electrostatic dry coating process for enteric coating of tablets with Eudragit® L100-55. Eur J Pharm Biopharm. 2013;83:293–300.
   PubMed Web of Science ®Google Scholar
• Yang QL, Ma YL, Zhu J. Applying a novel electrostatic dry powder coating technology to pellets. Eur J Pharm Biopharm. 2015;97:118–124.
   PubMed Web of Science ®Google Scholar
• Phoqus: development of tablet coating process [Internet]. Cambridge (UK): Sagentia; [cited 2017 Mar 22]. Available from: https://www.sagentia.com/case-study/phoqus-development-of-tablet-coating-process/
   Google Scholar
• Newell-Price J, Whiteman M, Rostami-Hodjegan A, et al. Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers. Clin Endocrinol (Oxf). 2008;68:130–135.
   PubMed Web of Science ®Google Scholar
• Mallappa A, Sinaii N, Kumar P, et al. A phase 2 study of chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2015;100:1137–1145.
   PubMed Web of Science ®Google Scholar
• Zema L, Loreti G, Melocchi A, et al. Injection molding and its application to drug delivery. J Control Release. 2012;159:324–331.
   PubMed Web of Science ®Google Scholar
• Groning R, Kuhlmann E, Muller RS. Biodegradation of high-tech drug delivery systems. Pharm Ind. 2008;70:1409–1413.
   Web of Science ®Google Scholar
• Bar-Shalom D, Slot L, Lee WW, et al. Development of the Egalet®Technology. In: Rathbone MJ, Hadgraft J, Roberts MS, editors. Modified-release drug delivery technology. New York: Marcel Dekker; 2003. p. 263–271.
   Google Scholar
• Egalet Corporation | Technology Overview [Internet]. [cited 2017 Mar 22]. Available from: http://egalet.com/rd/technology-overview
   Google Scholar
• Gazzaniga A, Cerea M, Cozzi A, et al. A novel injection-molded capsular device for oral pulsatile delivery based on swellable/erodible polymers. AAPS PharmSciTech. 2011;12:295–303.
   PubMed Web of Science ®Google Scholar
• Zema L, Loreti G, Macchi E, et al. Injection-molded capsular device for oral pulsatile release: development of a novel mold. J Pharm Sci. 2013;102:489–499.
   PubMed Web of Science ®Google Scholar
• Zema L, Loreti G, Melocchi A, et al. Gastroresistant capsular device prepared by injection molding. Int J Pharm. 2013;440:264–272.
   PubMed Web of Science ®Google Scholar
• Macchi E, Zema L, Maroni A, et al. Enteric-coating of pulsatile-release HPC capsules prepared by injection molding. Eur J Pharm Sci. 2015;70:1–11.
   PubMed Web of Science ®Google Scholar
• Melocchi A, Parietti F, Maroni A, et al. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. Int J Pharm. 2016;509:255–263.
   PubMed Web of Science ®Google Scholar
• Melocchi A, Parietti F, Loreti G, et al. 3D printing by fused deposition modeling (FDM) of a swellable/erodible capsular device for oral pulsatile release of drugs. J Drug Deliv Sci Technol. 2015;30:360–367.
   Web of Science ®Google Scholar
• Okwuosa TC, Pereira BC, Arafat B, et al. Fabricating a shell-core delayed release tablet using dual FDM 3D printing for patient-centred therapy. Pharm Res. 2016;34:427–437.
   PubMed Web of Science ®Google Scholar